Page last updated: 2024-08-26

farrerol and Ovarian Neoplasms

farrerol has been researched along with Ovarian Neoplasms in 1 studies

*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chae, J; Choi, ST; Kang, YJ; Kim, JS; Kwon, TK; Lee, SG; Nam, JO; Ojulari, OV	1

Other Studies

1 other study(ies) available for farrerol and Ovarian Neoplasms

Article	Year
Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis. International journal of molecular sciences, 2021, Aug-30, Volume: 22, Issue:17 Topics: Apoptosis; Cell Cycle; Cell Proliferation; Chromones; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Lipolysis; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2021

Article

Year

Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis.

International journal of molecular sciences, 2021, Aug-30, Volume: 22, Issue:17

Topics: Apoptosis; Cell Cycle; Cell Proliferation; Chromones; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Lipolysis; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2021